These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 9820479)
1. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. Brossay L; Naidenko O; Burdin N; Matsuda J; Sakai T; Kronenberg M J Immunol; 1998 Nov; 161(10):5124-8. PubMed ID: 9820479 [TBL] [Abstract][Full Text] [Related]
2. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842 [TBL] [Abstract][Full Text] [Related]
3. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969 [TBL] [Abstract][Full Text] [Related]
5. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
6. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics. Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739 [TBL] [Abstract][Full Text] [Related]
7. The surprising diversity of lipid antigens for CD1-restricted T cells. Moody DB Adv Immunol; 2006; 89():87-139. PubMed ID: 16682273 [TBL] [Abstract][Full Text] [Related]
8. CD1 proteins: targets of T cell recognition in innate and adaptive immunity. Ulrichs T; Porcelli SA Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748 [TBL] [Abstract][Full Text] [Related]
9. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells. Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902 [TBL] [Abstract][Full Text] [Related]
10. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. Cantu C; Benlagha K; Savage PB; Bendelac A; Teyton L J Immunol; 2003 May; 170(9):4673-82. PubMed ID: 12707346 [TBL] [Abstract][Full Text] [Related]
11. The crystal structure of human CD1d with and without alpha-galactosylceramide. Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090 [TBL] [Abstract][Full Text] [Related]
12. CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. Benlagha K; Bendelac A Semin Immunol; 2000 Dec; 12(6):537-42. PubMed ID: 11145859 [TBL] [Abstract][Full Text] [Related]
13. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells. Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291 [TBL] [Abstract][Full Text] [Related]
14. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160 [TBL] [Abstract][Full Text] [Related]
15. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763 [TBL] [Abstract][Full Text] [Related]
16. The in vivo response of invariant natural killer T cells to glycolipid antigens. Parekh VV; Lalani S; Van Kaer L Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263 [TBL] [Abstract][Full Text] [Related]
17. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Wu L; Gabriel CL; Parekh VV; Van Kaer L Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798 [TBL] [Abstract][Full Text] [Related]
18. Structural requirements for antigen presentation by mouse CD1. Burdin N; Brossay L; Degano M; Iijima H; Gui M; Wilson IA; Kronenberg M Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10156-61. PubMed ID: 10963678 [TBL] [Abstract][Full Text] [Related]
19. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules. Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930 [TBL] [Abstract][Full Text] [Related]
20. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells. Gui M; Li J; Wen LJ; Hardy RR; Hayakawa K J Immunol; 2001 Dec; 167(11):6239-46. PubMed ID: 11714786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]